APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lumpectomy

Women who’ve been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Women who’ve been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy).

A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure, whereas in mastectomy, the full breast is removed to avoid chances of cancer development in future.

Selected research

Market Analysis & Forecast

Global Lumpectomy Market Analysis and Forecast 2026-2032

Report ID 17389465021 January 2026190 pages

Choose your research edition.

Industry ResearchLumpectomy Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Lumpectomy Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Lumpectomy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lumpectomy Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Lumpectomy Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Women who’ve been recently diagnosed with breast cancer are almost immediately faced with treatment choices. The most common options are to remove the cancerous tissue in part of the breast (lumpectomy) or to remove the entire breast (mastectomy).

A lumpectomy is a form of breast-conserving and preservation surgery used for the removal of breast tumor or some surrounding tissues. It is also known as a partial mastectomy because a part of breast tissue is removed in this procedure, whereas in mastectomy, the full breast is removed to avoid chances of cancer development in future.

The industry's leading producers are Hologic, BD and Danaher, which accounted for 40.13%, 11.79% and 11.27% of revenue in 2019, respectively.

Read the full market overview

Report Includes

This report presents an overview of global market for Lumpectomy, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lumpectomy, also provides the revenue of main regions and countries. Of the upcoming market potential for Lumpectomy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lumpectomy revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lumpectomy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Lumpectomy revenue, projected growth trends, production technology, application and end-user industry.

Lumpectomy Segment by Company

Hologic

BD

Danaher

Cook Medical

Carl Zeiss Meditech

Merit Medical

Argon Medical Devices

Eckert & Ziegler

Theragenics

Sanarus

IsoAid

SOMATEX Medical

Ranfac

STERYLAB

Endomagnetics

Lumpectomy Segment by Type

Lumpectomy Systems

Lumpectomy Surgical Tools

Lumpectomy Segment by Application

Hospitals

Ambulatory Surgical Centers

Lumpectomy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lumpectomy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lumpectomy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lumpectomy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Lumpectomy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Lumpectomy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lumpectomy revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lumpectomy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Lumpectomy Systems Major Player Table 3. Lumpectomy Surgical Tools Major Player Table 4. Global Lumpectomy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Player Table 6. Ambulatory Surgical Centers Major Player Table 7. Lumpectomy Industry Trends Table 8. Lumpectomy Industry Drivers Table 9. Lumpectomy Industry Opportunities and Challenges Table 10. Lumpectomy Industry Restraints Table 11. Global Lumpectomy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Lumpectomy Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Lumpectomy Market Share by Region (2021-2026) Table 14. Global Lumpectomy Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Lumpectomy Market Share by Region (2027-2032) Table 16. Global Lumpectomy Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Lumpectomy Revenue Market Share by Players (2021-2026) Table 18. Global Lumpectomy Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Lumpectomy Key Players Headquarters & Area Served Table 20. Global Lumpectomy Players, Product Type & Application Table 21. Global Lumpectomy Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Lumpectomy by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Lumpectomy Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lumpectomy Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Lumpectomy Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Lumpectomy Revenue Market Share by Type (2021-2026) Table 28. Global Lumpectomy Revenue Market Share by Type (2027-2032) Table 29. Global Lumpectomy Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Lumpectomy Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Lumpectomy Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Lumpectomy Revenue Market Share by Application (2021-2026) Table 33. Global Lumpectomy Revenue Market Share by Application (2027-2032) Table 34. Hologic Company Information Table 35. Hologic Business Overview Table 36. Hologic Lumpectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Hologic Lumpectomy Product Portfolio Table 38. Hologic Recent Development Table 39. BD Company Information Table 40. BD Business Overview Table 41. BD Lumpectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. BD Lumpectomy Product Portfolio Table 43. BD Recent Development Table 44. Danaher Company Information Table 45. Danaher Business Overview Table 46. Danaher Lumpectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Danaher Lumpectomy Product Portfolio Table 48. Danaher Recent Development Table 49. Cook Medical Company Information Table 50. Cook Medical Business Overview Table 51. Cook Medical Lumpectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Cook Medical Lumpectomy Product Portfolio Table 53. Cook Medical Recent Development Table 54. Carl Zeiss Meditech Company Information Table 55. Carl Zeiss Meditech Business Overview Table 56. Carl Zeiss Meditech Lumpectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Carl Zeiss Meditech Lumpectomy Product Portfolio Table 58. Carl Zeiss Meditech Recent Development Table 59. Merit Medical Company Information Table 60. Merit Medical Business Overview Table 61. Merit Medical Lumpectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Merit Medical Lumpectomy Product Portfolio Table 63. Merit Medical Recent Development Table 64. Argon Medical Devices Company Information Table 65. Argon Medical Devices Business Overview Table 66. Argon Medical Devices Lumpectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Argon Medical Devices Lumpectomy Product Portfolio Table 68. Argon Medical Devices Recent Development Table 69. Eckert & Ziegler Company Information Table 70. Eckert & Ziegler Business Overview Table 71. Eckert & Ziegler Lumpectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Eckert & Ziegler Lumpectomy Product Portfolio Table 73. Eckert & Ziegler Recent Development Table 74. Theragenics Company Information Table 75. Theragenics Business Overview Table 76. Theragenics Lumpectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Theragenics Lumpectomy Product Portfolio Table 78. Theragenics Recent Development Table 79. Sanarus Company Information Table 80. Sanarus Business Overview Table 81. Sanarus Lumpectomy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Sanarus Lumpectomy Product Portfolio Table 83. Sanarus Recent Development Table 84. IsoAid Company Information Table 85. IsoAid Business Overview Table 86. IsoAid Lumpectomy Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 87. IsoAid Lumpectomy Product Portfolio Table 88. IsoAid Recent Development Table 89. SOMATEX Medical Company Information Table 90. SOMATEX Medical Business Overview Table 91. SOMATEX Medical Lumpectomy Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 92. SOMATEX Medical Lumpectomy Product Portfolio Table 93. SOMATEX Medical Recent Development Table 94. Ranfac Company Information Table 95. Ranfac Business Overview Table 96. Ranfac Lumpectomy Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 97. Ranfac Lumpectomy Product Portfolio Table 98. Ranfac Recent Development Table 99. STERYLAB Company Information Table 100. STERYLAB Business Overview Table 101. STERYLAB Lumpectomy Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 102. STERYLAB Lumpectomy Product Portfolio Table 103. STERYLAB Recent Development Table 104. Endomagnetics Company Information Table 105. Endomagnetics Business Overview Table 106. Endomagnetics Lumpectomy Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 107. Endomagnetics Lumpectomy Product Portfolio Table 108. Endomagnetics Recent Development Table 109. North America Lumpectomy Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Lumpectomy Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Lumpectomy Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Lumpectomy Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Lumpectomy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Lumpectomy Revenue by Country (2021-2026) & (US$ Million) Table 115. North America Lumpectomy Revenue by Country (US$ Million) & (2027-2032) Table 116. Europe Lumpectomy Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Lumpectomy Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Lumpectomy Revenue by Application (2021-2026) & (US$ Million) Table 119. Europe Lumpectomy Revenue by Application (2027-2032) & (US$ Million) Table 120. Europe Lumpectomy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Lumpectomy Revenue by Country (2021-2026) & (US$ Million) Table 122. Europe Lumpectomy Revenue by Country (US$ Million) & (2027-2032) Table 123. China Lumpectomy Revenue by Type (2021-2026) & (US$ Million) Table 124. China Lumpectomy Revenue by Type (2027-2032) & (US$ Million) Table 125. China Lumpectomy Revenue by Application (2021-2026) & (US$ Million) Table 126. China Lumpectomy Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Lumpectomy Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Lumpectomy Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Lumpectomy Revenue by Application (2021-2026) & (US$ Million) Table 130. Asia Lumpectomy Revenue by Application (2027-2032) & (US$ Million) Table 131. Asia Lumpectomy Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Asia Lumpectomy Revenue by Region (US$ Million) & (2021-2026) Table 133. Asia Lumpectomy Revenue by Region (US$ Million) & (2027-2032) Table 134. SAMEA Lumpectomy Revenue by Type (2021-2026) & (US$ Million) Table 135. SAMEA Lumpectomy Revenue by Type (2027-2032) & (US$ Million) Table 136. SAMEA Lumpectomy Revenue by Application (2021-2026) & (US$ Million) Table 137. SAMEA Lumpectomy Revenue by Application (2027-2032) & (US$ Million) Table 138. SAMEA Lumpectomy Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. SAMEA Lumpectomy Revenue by Country (2021-2026) & (US$ Million) Table 140. SAMEA Lumpectomy Revenue by Country (US$ Million) & (2027-2032) Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Lumpectomy Image Figure 2. Global Lumpectomy Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lumpectomy Market Size Share 2021 VS 2025 VS 2032 Figure 4. Lumpectomy Systems Image Figure 5. Lumpectomy Surgical Tools Image Figure 6. Global Lumpectomy Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Lumpectomy Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Ambulatory Surgical Centers Image Figure 10. Global Lumpectomy Market Size (US$ Million) & (2021-2032) Figure 11. Global Lumpectomy Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Lumpectomy Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Lumpectomy Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Lumpectomy Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Lumpectomy Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Lumpectomy Revenue Market Share by Type (2021-2032) Figure 18. Global Lumpectomy Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Lumpectomy Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Lumpectomy Revenue Market Share by Application (2021-2032) Figure 21. North America Lumpectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Lumpectomy Revenue Share by Type (2021-2032) Figure 23. North America Lumpectomy Revenue Share by Application (2021-2032) Figure 24. North America Lumpectomy Revenue Share by Country (2021-2032) Figure 25. United States Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Lumpectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Lumpectomy Revenue Share by Type (2021-2032) Figure 30. Europe Lumpectomy Revenue Share by Application (2021-2032) Figure 31. Europe Lumpectomy Revenue Share by Country (2021-2032) Figure 32. Germany Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Lumpectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Lumpectomy Revenue Share by Type (2021-2032) Figure 42. China Lumpectomy Revenue Share by Application (2021-2032) Figure 43. Asia Lumpectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Lumpectomy Revenue Share by Type (2021-2032) Figure 45. Asia Lumpectomy Revenue Share by Application (2021-2032) Figure 46. Asia Lumpectomy Revenue Share by Region (2021-2032) Figure 47. Japan Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Lumpectomy Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Lumpectomy Revenue Share by Type (2021-2032) Figure 55. SAMEA Lumpectomy Revenue Share by Application (2021-2032) Figure 56. SAMEA Lumpectomy Revenue Share by Country (2021-2032) Figure 57. Brazil Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Lumpectomy Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Lumpectomy Systems
  • Lumpectomy Surgical Tools
Applications
  • Hospitals
  • Ambulatory Surgical Centers
Companies covered
  • Hologic
  • BD
  • Danaher
  • Cook Medical
  • Carl Zeiss Meditech
  • Merit Medical
  • Argon Medical Devices
  • Eckert & Ziegler
  • Theragenics
  • Sanarus
  • IsoAid
  • SOMATEX Medical
  • Ranfac
  • STERYLAB
  • Endomagnetics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lumpectomy Market by Type
  3. 1.2.1 Global Lumpectomy Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Lumpectomy Systems
  5. 1.2.3 Lumpectomy Surgical Tools
  6. 1.3 Lumpectomy Market by Application
  7. 1.3.1 Global Lumpectomy Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Ambulatory Surgical Centers
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Lumpectomy Market Dynamics
  1. 2.1 Lumpectomy Industry Trends
  2. 2.2 Lumpectomy Industry Drivers
  3. 2.3 Lumpectomy Industry Opportunities and Challenges
  4. 2.4 Lumpectomy Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Lumpectomy Market Perspective (2021-2032)
  2. 3.2 Global Lumpectomy Growth Trends by Region
  3. 3.2.1 Global Lumpectomy Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lumpectomy Market Size by Region (2021-2026)
  5. 3.2.3 Global Lumpectomy Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Lumpectomy Revenue by Players
  2. 4.1.1 Global Lumpectomy Revenue by Players (2021-2026)
  3. 4.1.2 Global Lumpectomy Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Lumpectomy Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lumpectomy Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Lumpectomy Key Players Headquarters & Area Served
  7. 4.4 Global Lumpectomy Players, Product Type & Application
  8. 4.5 Global Lumpectomy Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Lumpectomy Market CR5 and HHI
  11. 4.6.3 2025 Lumpectomy Tier 1, Tier 2, and Tier 3
5 Lumpectomy Market Size by Type
  1. 5.1 Global Lumpectomy Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Lumpectomy Revenue by Type (2021-2032)
  3. 5.3 Global Lumpectomy Revenue Market Share by Type (2021-2032)
6 Lumpectomy Market Size by Application
  1. 6.1 Global Lumpectomy Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Lumpectomy Revenue by Application (2021-2032)
  3. 6.3 Global Lumpectomy Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Hologic
  2. 7.1.1 Hologic Company Information
  3. 7.1.2 Hologic Business Overview
  4. 7.1.3 Hologic Lumpectomy Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Hologic Lumpectomy Product Portfolio
  6. 7.1.5 Hologic Recent Developments
  7. 7.2 BD
  8. 7.2.1 BD Company Information
  9. 7.2.2 BD Business Overview
  10. 7.2.3 BD Lumpectomy Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BD Lumpectomy Product Portfolio
  12. 7.2.5 BD Recent Developments
  13. 7.3 Danaher
  14. 7.3.1 Danaher Company Information
  15. 7.3.2 Danaher Business Overview
  16. 7.3.3 Danaher Lumpectomy Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Danaher Lumpectomy Product Portfolio
  18. 7.3.5 Danaher Recent Developments
  19. 7.4 Cook Medical
  20. 7.4.1 Cook Medical Company Information
  21. 7.4.2 Cook Medical Business Overview
  22. 7.4.3 Cook Medical Lumpectomy Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Cook Medical Lumpectomy Product Portfolio
  24. 7.4.5 Cook Medical Recent Developments
  25. 7.5 Carl Zeiss Meditech
  26. 7.5.1 Carl Zeiss Meditech Company Information
  27. 7.5.2 Carl Zeiss Meditech Business Overview
  28. 7.5.3 Carl Zeiss Meditech Lumpectomy Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Carl Zeiss Meditech Lumpectomy Product Portfolio
  30. 7.5.5 Carl Zeiss Meditech Recent Developments
  31. 7.6 Merit Medical
  32. 7.6.1 Merit Medical Company Information
  33. 7.6.2 Merit Medical Business Overview
  34. 7.6.3 Merit Medical Lumpectomy Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Merit Medical Lumpectomy Product Portfolio
  36. 7.6.5 Merit Medical Recent Developments
  37. 7.7 Argon Medical Devices
  38. 7.7.1 Argon Medical Devices Company Information
  39. 7.7.2 Argon Medical Devices Business Overview
  40. 7.7.3 Argon Medical Devices Lumpectomy Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Argon Medical Devices Lumpectomy Product Portfolio
  42. 7.7.5 Argon Medical Devices Recent Developments
  43. 7.8 Eckert & Ziegler
  44. 7.8.1 Eckert & Ziegler Company Information
  45. 7.8.2 Eckert & Ziegler Business Overview
  46. 7.8.3 Eckert & Ziegler Lumpectomy Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Eckert & Ziegler Lumpectomy Product Portfolio
  48. 7.8.5 Eckert & Ziegler Recent Developments
  49. 7.9 Theragenics
  50. 7.9.1 Theragenics Company Information
  51. 7.9.2 Theragenics Business Overview
  52. 7.9.3 Theragenics Lumpectomy Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Theragenics Lumpectomy Product Portfolio
  54. 7.9.5 Theragenics Recent Developments
  55. 7.10 Sanarus
  56. 7.10.1 Sanarus Company Information
  57. 7.10.2 Sanarus Business Overview
  58. 7.10.3 Sanarus Lumpectomy Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Sanarus Lumpectomy Product Portfolio
  60. 7.10.5 Sanarus Recent Developments
  61. 7.11 IsoAid
  62. 7.11.1 IsoAid Company Information
  63. 7.11.2 IsoAid Business Overview
  64. 7.11.3 IsoAid Lumpectomy Revenue and Gross Margin (2021-2026)
  65. 7.11.4 IsoAid Lumpectomy Product Portfolio
  66. 7.11.5 IsoAid Recent Developments
  67. 7.12 SOMATEX Medical
  68. 7.12.1 SOMATEX Medical Company Information
  69. 7.12.2 SOMATEX Medical Business Overview
  70. 7.12.3 SOMATEX Medical Lumpectomy Revenue and Gross Margin (2021-2026)
  71. 7.12.4 SOMATEX Medical Lumpectomy Product Portfolio
  72. 7.12.5 SOMATEX Medical Recent Developments
  73. 7.13 Ranfac
  74. 7.13.1 Ranfac Company Information
  75. 7.13.2 Ranfac Business Overview
  76. 7.13.3 Ranfac Lumpectomy Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Ranfac Lumpectomy Product Portfolio
  78. 7.13.5 Ranfac Recent Developments
  79. 7.14 STERYLAB
  80. 7.14.1 STERYLAB Company Information
  81. 7.14.2 STERYLAB Business Overview
  82. 7.14.3 STERYLAB Lumpectomy Revenue and Gross Margin (2021-2026)
  83. 7.14.4 STERYLAB Lumpectomy Product Portfolio
  84. 7.14.5 STERYLAB Recent Developments
  85. 7.15 Endomagnetics
  86. 7.15.1 Endomagnetics Company Information
  87. 7.15.2 Endomagnetics Business Overview
  88. 7.15.3 Endomagnetics Lumpectomy Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Endomagnetics Lumpectomy Product Portfolio
  90. 7.15.5 Endomagnetics Recent Developments
8 North America
  1. 8.1 North America Lumpectomy Revenue (2021-2032)
  2. 8.2 North America Lumpectomy Revenue by Type (2021-2032)
  3. 8.2.1 North America Lumpectomy Revenue by Type (2021-2026)
  4. 8.2.2 North America Lumpectomy Revenue by Type (2027-2032)
  5. 8.3 North America Lumpectomy Revenue Share by Type (2021-2032)
  6. 8.4 North America Lumpectomy Revenue by Application (2021-2032)
  7. 8.4.1 North America Lumpectomy Revenue by Application (2021-2026)
  8. 8.4.2 North America Lumpectomy Revenue by Application (2027-2032)
  9. 8.5 North America Lumpectomy Revenue Share by Application (2021-2032)
  10. 8.6 North America Lumpectomy Revenue by Country
  11. 8.6.1 North America Lumpectomy Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Lumpectomy Revenue by Country (2021-2026)
  13. 8.6.3 North America Lumpectomy Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Lumpectomy Revenue (2021-2032)
  2. 9.2 Europe Lumpectomy Revenue by Type (2021-2032)
  3. 9.2.1 Europe Lumpectomy Revenue by Type (2021-2026)
  4. 9.2.2 Europe Lumpectomy Revenue by Type (2027-2032)
  5. 9.3 Europe Lumpectomy Revenue Share by Type (2021-2032)
  6. 9.4 Europe Lumpectomy Revenue by Application (2021-2032)
  7. 9.4.1 Europe Lumpectomy Revenue by Application (2021-2026)
  8. 9.4.2 Europe Lumpectomy Revenue by Application (2027-2032)
  9. 9.5 Europe Lumpectomy Revenue Share by Application (2021-2032)
  10. 9.6 Europe Lumpectomy Revenue by Country
  11. 9.6.1 Europe Lumpectomy Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Lumpectomy Revenue by Country (2021-2026)
  13. 9.6.3 Europe Lumpectomy Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Lumpectomy Revenue (2021-2032)
  2. 10.2 China Lumpectomy Revenue by Type (2021-2032)
  3. 10.2.1 China Lumpectomy Revenue by Type (2021-2026)
  4. 10.2.2 China Lumpectomy Revenue by Type (2027-2032)
  5. 10.3 China Lumpectomy Revenue Share by Type (2021-2032)
  6. 10.4 China Lumpectomy Revenue by Application (2021-2032)
  7. 10.4.1 China Lumpectomy Revenue by Application (2021-2026)
  8. 10.4.2 China Lumpectomy Revenue by Application (2027-2032)
  9. 10.5 China Lumpectomy Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lumpectomy Revenue (2021-2032)
  2. 11.2 Asia Lumpectomy Revenue by Type (2021-2032)
  3. 11.2.1 Asia Lumpectomy Revenue by Type (2021-2026)
  4. 11.2.2 Asia Lumpectomy Revenue by Type (2027-2032)
  5. 11.3 Asia Lumpectomy Revenue Share by Type (2021-2032)
  6. 11.4 Asia Lumpectomy Revenue by Application (2021-2032)
  7. 11.4.1 Asia Lumpectomy Revenue by Application (2021-2026)
  8. 11.4.2 Asia Lumpectomy Revenue by Application (2027-2032)
  9. 11.5 Asia Lumpectomy Revenue Share by Application (2021-2032)
  10. 11.6 Asia Lumpectomy Revenue by Country
  11. 11.6.1 Asia Lumpectomy Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Lumpectomy Revenue by Country (2021-2026)
  13. 11.6.3 Asia Lumpectomy Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lumpectomy Revenue (2021-2032)
  2. 12.2 SAMEA Lumpectomy Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Lumpectomy Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Lumpectomy Revenue by Type (2027-2032)
  5. 12.3 SAMEA Lumpectomy Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Lumpectomy Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Lumpectomy Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Lumpectomy Revenue by Application (2027-2032)
  9. 12.5 SAMEA Lumpectomy Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Lumpectomy Revenue by Country
  11. 12.6.1 SAMEA Lumpectomy Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Lumpectomy Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Lumpectomy Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst